FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384126670> ?p ?o ?g. }

• W4384126670 abstract "Abstract Introduction Data from two randomized controlled trials (RCTs) showed that injectable cabotegravir (CAB) for pre‐exposure prophylaxis (PrEP) was efficacious in reducing HIV acquisition. The US Food and Drug Administration approved CAB for PrEP in December 2021; Australia in August 2022; Zimbabwe in October 2022; South Africa in November 2022; Malawi in March 2023; and regulatory approvals are being sought in additional countries. The World Health Organization (WHO) recommended CAB be offered to people at substantial risk of HIV in July 2022. However, implementation experience beyond RCTs is limited. As countries consider CAB implementation, questions remain regarding delivery and involvement of populations excluded from the trials. A coordinated approach is needed to ensure these are addressed and CAB can be introduced in low‐ and middle‐income countries in timely, acceptable and effective ways. Discussion Beginning in 2018, the Biomedical Prevention Implementation Collaborative (BioPIC) convened over 100 global health experts to develop a comprehensive introduction strategy for CAB. Using this roadmap, country landscaping for CAB introduction and lessons from oral PrEP implementation, AVAC and WHO co‐convened 50 researchers, donors, implementers and civil society in September 2021 to: (1) identify questions and evidence gaps related to CAB across contexts and partners; (2) define the implementation science agenda; and (3) agree on mechanism(s) for future coordination. As a result, CAB‐related questions were identified, including: defining optimal and feasible HIV testing strategies that expand access; delivery models; integration with a range of services, including family planning and antenatal care; and embedding CAB in demand generation for HIV prevention choices. Through convenings and mapping of implementation research, BioPIC identified gaps in populations, geographies and delivery approaches. Conclusions The introduction strategy refined by BioPIC lays the groundwork for future HIV prevention products. Ongoing policy and implementation dialogue is critical to accelerate the design of CAB implementation studies that adequately address priority knowledge gaps. Additional long‐acting HIV prevention products may be available over the next 5 years, increasing choice, but potentially making delivery and stakeholder engagement more complex. Ongoing coordination with WHO will accelerate the adoption of evidence‐based policies and wide‐scale implementation, and lessons from BioPIC can inform introduction processes for long‐acting HIV prevention products." @default.
• W4384126670 created "2023-07-14" @default.
• W4384126670 creator A5009698136 @default.
• W4384126670 creator A5054702303 @default.
• W4384126670 creator A5062584415 @default.
• W4384126670 creator A5068806732 @default.
• W4384126670 creator A5071458863 @default.
• W4384126670 creator A5082593678 @default.
• W4384126670 creator A5092457901 @default.
• W4384126670 date "2023-07-01" @default.
• W4384126670 modified "2023-09-25" @default.
• W4384126670 title "Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC)" @default.
• W4384126670 cites W3190424399 @default.
• W4384126670 cites W4226116413 @default.
• W4384126670 cites W4283020733 @default.
• W4384126670 cites W4288494273 @default.
• W4384126670 doi "https://doi.org/10.1002/jia2.26094" @default.
• W4384126670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37439050" @default.
• W4384126670 hasPublicationYear "2023" @default.
• W4384126670 type Work @default.
• W4384126670 citedByCount "1" @default.
• W4384126670 countsByYear W43841266702023 @default.
• W4384126670 crossrefType "journal-article" @default.
• W4384126670 hasAuthorship W4384126670A5009698136 @default.
• W4384126670 hasAuthorship W4384126670A5054702303 @default.
• W4384126670 hasAuthorship W4384126670A5062584415 @default.
• W4384126670 hasAuthorship W4384126670A5068806732 @default.
• W4384126670 hasAuthorship W4384126670A5071458863 @default.
• W4384126670 hasAuthorship W4384126670A5082593678 @default.
• W4384126670 hasAuthorship W4384126670A5092457901 @default.
• W4384126670 hasBestOaLocation W43841266701 @default.
• W4384126670 hasConcept C159110408 @default.
• W4384126670 hasConcept C17744445 @default.
• W4384126670 hasConcept C27415008 @default.
• W4384126670 hasConcept C2776939746 @default.
• W4384126670 hasConcept C2776983459 @default.
• W4384126670 hasConcept C2779496540 @default.
• W4384126670 hasConcept C3013748606 @default.
• W4384126670 hasConcept C39549134 @default.
• W4384126670 hasConcept C509550671 @default.
• W4384126670 hasConcept C512399662 @default.
• W4384126670 hasConcept C71924100 @default.
• W4384126670 hasConcept C72497813 @default.
• W4384126670 hasConceptScore W4384126670C159110408 @default.
• W4384126670 hasConceptScore W4384126670C17744445 @default.
• W4384126670 hasConceptScore W4384126670C27415008 @default.
• W4384126670 hasConceptScore W4384126670C2776939746 @default.
• W4384126670 hasConceptScore W4384126670C2776983459 @default.
• W4384126670 hasConceptScore W4384126670C2779496540 @default.
• W4384126670 hasConceptScore W4384126670C3013748606 @default.
• W4384126670 hasConceptScore W4384126670C39549134 @default.
• W4384126670 hasConceptScore W4384126670C509550671 @default.
• W4384126670 hasConceptScore W4384126670C512399662 @default.
• W4384126670 hasConceptScore W4384126670C71924100 @default.
• W4384126670 hasConceptScore W4384126670C72497813 @default.
• W4384126670 hasIssue "S2" @default.
• W4384126670 hasLocation W43841266701 @default.
• W4384126670 hasLocation W43841266702 @default.
• W4384126670 hasOpenAccess W4384126670 @default.
• W4384126670 hasPrimaryLocation W43841266701 @default.
• W4384126670 hasRelatedWork W1973460911 @default.
• W4384126670 hasRelatedWork W2096903645 @default.
• W4384126670 hasRelatedWork W2136985213 @default.
• W4384126670 hasRelatedWork W2149708245 @default.
• W4384126670 hasRelatedWork W2580575427 @default.
• W4384126670 hasRelatedWork W2748952813 @default.
• W4384126670 hasRelatedWork W2769164663 @default.
• W4384126670 hasRelatedWork W2883964143 @default.
• W4384126670 hasRelatedWork W2899084033 @default.
• W4384126670 hasRelatedWork W3012083753 @default.
• W4384126670 hasVolume "26" @default.
• W4384126670 isParatext "false" @default.
• W4384126670 isRetracted "false" @default.
• W4384126670 workType "article" @default.